DAIC
JUNE 21, 2024
milla1cf Fri, 06/21/2024 - 20:10 June 21, 2024 — UC San Francisco interventional cardiologists and interventional echocardiographers recently performed the health system’s first commercial transcatheter tricuspid valve replacement procedure using the Edwards EVOQUE system. by the Food and Drug Administration.
DAIC
FEBRUARY 18, 2025
In tricuspid valve regurgitation, a complex condition that Cedars-Sinai experts regularly treat, the valve between two heart chambers on the right side doesn't open or close properly. Makkar explained the advances for patients with tricuspid valve disease in a conversationwith the Cedars-Sinai Newsroom. Image by Getty. Image by Getty.
American College of Cardiology
OCTOBER 27, 2024
Food and Drug Administration (FDA) this year for tricuspid regurgitation (TR) are safe, effective and improve quality of life (QOL) at one year, according to studies published in JACC and simultaneously being presented at TCT 2024. Two devices approved by the U.S.
DAIC
APRIL 25, 2024
milla1cf Thu, 04/25/2024 - 17:21 April 25, 2024 — Atlantic Health System ’s Morristown Medical Center treated the first patient in New Jersey using Edwards Lifesciences EVOQUE tricuspid valve replacement, the first transcatheter therapy to receive U.S. According to National Institutes of Health an estimated 1.6 million people in the U.S.
DAIC
FEBRUARY 2, 2024
Photo: Edwards Lifesciences milla1cf Fri, 02/02/2024 - 09:33 February 2, 2024 — Edwards Lifesciences Corporation announced the company’s EVOQUE tricuspid valve replacement system is the first transcatheter therapy to receive U.S. Food and Drug Administration (FDA) approval for the treatment of tricuspid regurgitation (TR).
DAIC
FEBRUARY 15, 2024
Food and Drug Administration ( FDA ) confirmed 13 to 1, with 0 abstention that the benefits of Abbott's TriClip™ transcatheter edge-to-edge repair (TEER) system outweighed the risks for the treatment of people with tricuspid regurgitation (TR). On the final question of the benefit of TriClip versus the risk, the vote was 13 to 1 in favor.
DAIC
JUNE 10, 2024
milla1cf Mon, 06/10/2024 - 17:58 June 10, 2024 — Atrium Health Sanger Heart & Vascular Institute has successfully completed the first commercial tricuspid clip procedure in the Carolinas, performed in May at Atrium Health Carolinas Medical Center. The recent approval of the tricuspid clip device by the U.S.
Expert insights. Personalized for you.
105 
Let's personalize your content